Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma: A randomized phase 3 study

  1. Buske, C.
  2. Jurczak, W.
  3. Sancho, J.-M.
  4. Zhavrid, E.
  5. Kim, J.S.
  6. Hernandez-Rivas, J.-A.
  7. Prokharau, A.
  8. Vasilica, M.
  9. Nagarkar, R.
  10. Kwak, L.
  11. Kim, W.-S.
  12. Lee, S.
  13. Kim, S.
  14. Ahn, K.
  15. Ogura, M.
Journal:
Blood Advances

ISSN: 2473-9537 2473-9529

Year of publication: 2021

Volume: 5

Issue: 17

Pages: 3354-3361

Type: Article

DOI: 10.1182/BLOODADVANCES.2021004484 GOOGLE SCHOLAR lock_openOpen access editor